Zai Lab Limited (FRA:1ZL)
Germany · Delayed Price · Currency is EUR 15.30
-0.60 (-3.77%)
At close: Jan 23, 2026
Zai Lab Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| 441.63 | 398.99 | 266.72 | 215.04 | 144.31 | 48.96 | |
Revenue Growth (YoY) | 24.14% | 49.59% | 24.03% | 49.01% | 194.77% | 277.04% |
Cost of Revenue | 401.07 | 382.36 | 361.68 | 360.43 | 625.55 | 239.45 |
Gross Profit | 40.56 | 16.62 | -94.97 | -145.39 | -481.23 | -190.49 |
Selling, General & Admin | 287.18 | 298.74 | 281.61 | 258.97 | 218.83 | 111.31 |
Research & Development | -18.71 | - | - | - | - | - |
Operating Expenses | 268.47 | 298.74 | 281.61 | 258.97 | 218.83 | 111.31 |
Operating Income | -227.92 | -282.12 | -376.57 | -404.36 | -700.06 | -301.8 |
Interest Expense | -4.75 | -2.25 | - | - | - | -0.18 |
Interest & Investment Income | 34.88 | 37.11 | 39.8 | 14.58 | 2.19 | 5.12 |
Earnings From Equity Investments | - | - | - | -0.22 | -1.06 | -1.12 |
Currency Exchange Gain (Loss) | -13.51 | -15.14 | -14.85 | -56.4 | 4.66 | 21.66 |
Other Non Operating Income (Expenses) | 6.44 | 11.41 | 4.22 | 12.07 | 4.42 | 7.42 |
EBT Excluding Unusual Items | -204.86 | -251 | -347.41 | -434.33 | -689.85 | -268.91 |
Gain (Loss) on Sale of Investments | -1.95 | -6.11 | 2.79 | -8.95 | -14.62 | - |
Gain (Loss) on Sale of Assets | - | - | 10 | - | - | - |
Pretax Income | -206.81 | -257.1 | -334.62 | -443.29 | -704.47 | -268.91 |
Net Income | -206.81 | -257.1 | -334.62 | -443.29 | -704.47 | -268.91 |
Net Income to Common | -206.81 | -257.1 | -334.62 | -443.29 | -704.47 | -268.91 |
Shares Outstanding (Basic) | 108 | 99 | 97 | 96 | 93 | 78 |
Shares Outstanding (Diluted) | 108 | 99 | 97 | 96 | 93 | 78 |
Shares Change (YoY) | 10.28% | 2.39% | 0.87% | 3.03% | 19.73% | 20.66% |
EPS (Basic) | -1.92 | -2.60 | -3.46 | -4.63 | -7.58 | -3.46 |
EPS (Diluted) | -1.92 | -2.60 | -3.46 | -4.63 | -7.58 | -3.46 |
Free Cash Flow | -190.56 | -220.53 | -205.39 | -392.23 | -567.53 | -226.19 |
Free Cash Flow Per Share | -1.77 | -2.23 | -2.13 | -4.09 | -6.10 | -2.91 |
Gross Margin | 9.18% | 4.17% | -35.60% | -67.61% | - | - |
Operating Margin | -51.61% | -70.71% | -141.19% | -188.04% | -485.10% | -616.45% |
Profit Margin | -46.83% | -64.44% | -125.46% | -206.14% | -488.16% | -549.26% |
Free Cash Flow Margin | -43.15% | -55.27% | -77.01% | -182.40% | -393.26% | -462.00% |
EBITDA | -213.79 | -270.26 | -367.54 | -396.13 | -693.58 | -297.16 |
EBITDA Margin | -48.41% | -67.74% | -137.80% | -184.21% | - | - |
D&A For EBITDA | 14.13 | 11.86 | 9.03 | 8.23 | 6.49 | 4.64 |
EBIT | -227.92 | -282.12 | -376.57 | -404.36 | -700.06 | -301.8 |
EBIT Margin | -51.61% | -70.71% | -141.19% | -188.04% | - | - |
Revenue as Reported | 441.63 | 398.99 | 266.72 | 215.04 | 144.31 | 48.96 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.